Please wait a minute...
文章检索
预防医学  2022, Vol. 34 Issue (5): 519-524    DOI: 10.19485/j.cnki.issn2096-5087.2022.05.020
  疾病控制 本期目录 | 过刊浏览 | 高级检索 |
墨玉县居民代谢性疾病患病调查
呼聪慧1, 苏银霞2, 阿力米热·阿布迪热依木1, 姚华2
1.新疆医科大学公共卫生学院,新疆 乌鲁木齐 830000;
2.新疆医科大学,新疆 乌鲁木齐 830000
Investigation on the prevalence of metabolic diseases among residentsin Moyu County
HU Conghui1, SU Yinxia2, Alimire Abudireyimu1, YAO Hua2
1. School of Public Health, Xinjiang Medical University, Urumqi, Xinjiang 830000, China;
2. Xinjiang Medical University, Urumqi, Xinjiang 830000, China
全文: PDF(986 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 了解新疆和田地区墨玉县居民代谢性疾病患病情况,为制定代谢性疾病防控策略提供依据。方法 通过医院体检病历系统收集2020年墨玉县≥18岁居民的人口学信息、实验室检测和肝胆B超检测资料,分析墨玉县居民肥胖、高血压、糖尿病、血脂异常和脂肪肝等代谢性疾病患病情况。采用多分类logistic回归模型分析代谢性疾病的影响因素。结果 调查281 803人,其中男性129 549人,占49.97%;女性152 254人,占54.03%。年龄MQR)为37.00(22.00)岁。患代谢性疾病134 306例,患病率为47.66%;其中,肥胖、高血压、血脂异常、脂肪肝和糖尿病的患病率分别为25.72%、24.77%、12.30%、12.05%和5.49%,均随年龄增长呈上升趋势(χ2趋势=11 243.73、14 086.41、2 109.70、6 631.22、2 011.15,均P<0.001)。患1种代谢性疾病73 811例,占26.19%;患多种代谢性疾病60 495例,占21.47%。多分类logistic回归分析结果显示,性别(OR=0.870;0.796)、年龄(OR:1.703~8.701;2.952~18.846)、婚姻状况(OR:1.397~1.845;1.460~2.377)、文化程度(OR:0.891~0.937;0.920~0.924)、职业(OR:1.177~1.270;1.114~2.099)、家族史(OR=1.136;1.390)、饮酒频率(OR:2.038;1.395~2.574)和中心性肥胖(OR=3.448;14.352)与患1种和多种代谢性疾病有统计学关联。结论 墨玉县居民代谢性疾病患病率较高。男性、中老年人、文化程度低和不健康生活方式可能增加代谢性疾病的患病风险。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
呼聪慧
苏银霞
阿力米热·阿布迪热依木
姚华
关键词 代谢性疾病肥胖高血压糖尿病血脂异常    
AbstractObjective To investigate the prevalence of metabolic diseases among residents in Moyu County, Hotan Prefecture, Xinjiang Uygur Autonomous Region, so as to provide the evidence for developing the control strategy for metabolic diseases. Methods The demographic features, laboratory examinations and B-mode ultrasonographic examinations of the liver and gall bladder were collected from residents at ages of 18 years and older in Moyu County through the hospital-based medical records system. The prevalence of metabolic diseases was estimated, including obesity, hypertension, diabetes, dyslipidemia and fatty liver, and the factors affecting the development of metabolic diseases were identified using a multinomial logistic regression model. Results Totally 281 803 residents were included in the study, including 129 549 men ( 49.97% ) and 152 254 women ( 54.03% ) and with a median age of 37.00 years ( interquartile range, 22.00 years ). The overall prevalence of metabolic diseases was 47.66%, and the prevalence rates of obesity, hypertension, dyslipidemia, fatty liver and diabetes were 25.72%, 24.77%, 12.30%, 12.05% and 5.49%, respectively, which appeared a tendency towards a rise with age ( χ2trend = 11 243.73, 14 086.41, 2 109.70, 6 631.22, and 2 011.15, all P<0.001 ). There were 73 811 residents suffering from one metabolic disease (26.19%), and 60 495 residents with two and more metabolic diseases ( 21.47% ). Multinomial logistic regression analysis showed that gender ( OR=0.870; 0.796 ), age ( OR: 1.703-8.701; 2.952-18.846 ), marital status ( OR: 1.397-1.845; 1.460-2.377 ) educational level ( OR: 0.891-0.937; 0.920-0.924 ), occupation ( OR: 1.177-1.270; 1.114-2.099), family history ( OR=1.136; 1.390), drinking frequency ( OR: 2.038; 1.395-2.574 ) and central obesity ( OR=3.448; 14.352 ) were factors affecting the development of one or more metabolic diseases. Conclusion The prevalence of metabolic diseases is high among residents in Moyu County. Men, the elderly, a low education level and unhealthy lifestyles may increase the risk of metabolic diseases.
Key wordsmetabolic disease    obesity    hypertension    diabetes    dyslipidemia
收稿日期: 2021-11-02      修回日期: 2022-03-04     
中图分类号:  R589  
基金资助:国家自然科学基金项目(81960608)
通信作者: 姚华,E-mail:yaohua01@sina.com   
作者简介: 呼聪慧,硕士研究生在读
引用本文:   
呼聪慧, 苏银霞, 阿力米热·阿布迪热依木, 姚华. 墨玉县居民代谢性疾病患病调查[J]. 预防医学, 2022, 34(5): 519-524.
HU Conghui, SU Yinxia, Alimire Abudireyimu, YAO Hua. Investigation on the prevalence of metabolic diseases among residentsin Moyu County. Preventive Medicine, 2022, 34(5): 519-524.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2022.05.020      或      http://www.zjyfyxzz.com/CN/Y2022/V34/I5/519
[1] 吴娜娜. 不同体质与慢性代谢性疾病相关性研究进展[J].中医药临床杂志,2018,30(9):1771-1775.
WU N N.Research progress of correlation between different physique and chronic metabolic diseases[J].Clin J Tradit Chin Med,2018,30(9):1771-1775.
[2] 陈莹,梅勇.荆门某化工厂职工代谢性疾病的调查分析[J].中国卫生产业,2019,16(22):185-187.
CHEN Y,MEI Y.Investigation and analysis of metabolic diseases among workers in a chemical plant in Jingmen[J].Chin Health Ind,2019,16(22):185-187.
[3] 郭佩,李春君,张莉,等.天津市成人代谢性疾病共病患病率及其影响因素[J].职业与健康,2021,37(22):3061-3066,3071.
GUO P,LI C J,ZHANG L,et al.Prevalence of metabolic disease multimorbidity and its influencing factors among adults in Tianjin[J].Occup Health,2010,37(22):3061-3066,3071.
[4] HUANG Y,KARURANGA S,MALANDA B,et al.Call for data contribution to the IDF diabetes atlas 9th edition 2019[J].Diabetes Res Clin Pract,2018,140:351-352.
[5] 诸骏仁,高润霖,赵水平,等.中国成人血脂异常防治指南(2016年修订版)[J].中华健康管理学杂志,2017,11(1):7-28.
ZHU J R,GAO R L,ZHAO S P,et al.2016 Chinese guideline for the management of dyslipidemia in adults[J].Chin J Health Manag,2017,11(1):7-28.
[6] 国家卫生健康委员会疾病预防控制局,中华心血管病杂志编辑委员会,国家心血管病中心,等.中国高血压健康管理规范(2019)[J].中华心血管病杂志,2020,48(1):10-46.
Bureau of Disease Control and Prevention,National Health Commission,Editorial Board of Chinese Journal of Cardiovascular Diseases,National Cardiovascular Center,et al.National guideline for hypertension management in China(2019)[J].Chin J Cardiol,2020,48(1):10-46.
[7] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)(上)[J].中华糖尿病杂志,2021,13(4):315-409.
Chinese Diabetes Society.Guideline for the prevention and treatment of type 2 diabetes mellitus in China(2020 edition)[J].Chin J Diabetes Mellit,2021,13(4):315-409.
[8] 中华人民共和国卫生部.中国成人超重和肥胖症预防控制指南[M].北京:人民卫生出版社,2006.
Ministry of Health of the People's Republic of China.Guidelines for the prevention and control of overweight and obesity in adults in China[M].Beijing:People's Medical Publishing House,2006.
[9] 中华医学会肝病学分会脂肪肝和酒精性肝病学组,中国医师协会脂肪性肝病专家委员会.非酒精性脂肪性肝病防治指南(2018年更新版)[J].实用肝脏病杂志,2018,21(2):177-186.
Liver and Alcoholic Liver Disease,Chinese Society of Hepatology,Chinese Medical Association,Fatty Liver Expert Committee,Chinese Medical Doctor Association.Guidelines of prevention and treatment for nonalcoholic fatty liver disease:a 2018 update[J].J Pract Hepatol,2018,21(2):177-186.
[10] 中华医学会健康管理学分会,中华健康管理学杂志编委会.健康体检基本项目专家共识[J].中华健康管理学杂志,2014,8(2):81-90.
Chinese Medical Association Health Management Association,Editorial Board of Chinese Journal of Health Management.Expert consensus on basic items of health checkup[J].Chin J Health Manag,2014,8(2):81-90.
[11] 李文丽,苏银霞,诸葛瑾慧,等.新疆新源县居民慢性病患病现状及影响因素[J].职业与健康,2021,37(5):639-643.
LI W L,SU Y X,ZHUGE J H,et al.Prevalence and influencing factors of chronic diseases among residents in Xinyuan County of Xinjiang[J].Occup Health,2021,37(5):639-643.
[12] 张国珍,田恬,裴华莲,等.新疆和田地区墨玉县35~74岁人群睡眠状况与慢性病共病关系的研究[J].新疆医科大学学报,2019,42(10):1244-1248,1254.
ZHANG G Z,TIAN T,PEI H L,et al.Study of the relationship between the sleep status and chronic comorbidities among people aged 35-74 years of Moyu,Hetian,Xinjiang[J].J Xinjiang Med Univ,2019,42(10):1244-1248,1254.
[13] 迪娜·木合亚提,吕梅霞,菲罗娜·帕尔哈提,等.2018年和田县农村居民体质指数、腰围与血脂的相关性分析[J].预防医学论坛,2021,27(1):10-12,16.
[14] 卡米拉·牙尔买买提.新疆和田地区维吾尔族居民健康素养及生活方式调查分析[D].乌鲁木齐:新疆医科大学,2019.
[15] 段晓阳,李敏,祁志刚,等.高血压家族史和行为危险因素聚集与高血压患病关系[J].中国公共卫生,2022,38(2):172-176.
DUAN X Y,LI M,QI Z G,et al.The relationship between family history of hypertension and behavioral risk factor aggregation and the prevalence of hypertension[J].Chin J Public Health,2022,38(2):172-176.
[16] 张周斌,薛振香,陈海燕,等.新疆喀什地区维吾尔族人群高血压流行现状及危险因素分析[J].中华流行病学杂志,2017,38(6):709-714.
ZHANG Z B,XUE Z X,CHEN H Y,et al.Prevalence of hypertension and risk factors in Uygur population in Kashgar area of Xinjiang Uygur Autonomous Region[J].Chin J Epidemiol,2017,38(6):709-714.
[17] 马建军,高静,罗俊一,等.新疆阿克苏地区维吾尔族35岁以上人群血脂异常患病率、知晓率、治疗率及控制率的调查研究[J].中国动脉硬化杂志,2016,24(10):1050-1054.
MA J J,GAO J,LUO J Y,et al.The prevalence, awareness rate, treatment rate and control rate of dyslipidemia among Uygur people over 35 years old in Aksu of Xinjiang[J].Chin J Arterioscler,2016,24(10):1050-1054.
[18] 杨娟,郑晓,候丽红,等.太原市老年人多重慢病患病现状及影响因素[J].中华疾病控制杂志,2021,25(1):78-83,107.
YANG J,ZHENG X,HOU L H,et al.The prevalence and influencing factors of multiple chronic diseases in the elderly in Taiyuan[J].Chin J Dis Control,2021,25(1):78-83,107.
[1] 张铁威, 张艳, 刘冰, 秦康, 李标, 徐珏. 2013—2021年杭州市糖尿病死亡及疾病负担分析[J]. 预防医学, 2023, 35(9): 752-756.
[2] 王梦琴, 柴荟琳, 郭宇燕, 任敬娟, 梁瑞峰. 山西省农村居民高血压防治知识、态度、行为调查[J]. 预防医学, 2023, 35(7): 563-569.
[3] 张丹平, 徐玲妙. 糖尿病与血管性痴呆发病的关联、病理机制及防治策略研究[J]. 预防医学, 2023, 35(7): 582-586.
[4] 柏旭, 苏洁, 李凤, 徐倩, 沈源, 肖凌凤. 我国成人糖尿病视网膜病变影响因素的Meta分析[J]. 预防医学, 2023, 35(7): 595-601.
[5] 聂东梅, 李一鹏, 黄妍. 2012—2021年江门市4类慢性病早死概率分析[J]. 预防医学, 2023, 35(7): 602-606.
[6] 沈益妹, 章奇, 朱新凤, 丁晶莹, 俞梅华. 湖州市血压控制未达标高血压患者慢性病共病及影响因素分析[J]. 预防医学, 2023, 35(6): 541-545,550.
[7] 丁承辉, 吴萃, 薛琨, 励晓红, 万金豹, 陈秋艳, 朱潇翔. 宝山区糖尿病高危人群筛查结果分析[J]. 预防医学, 2023, 35(6): 509-513.
[8] 沈放如, 杨可, 刘厚璞, 朱家豪, 李迎君. 新生儿出生体重与母亲2型糖尿病关联的双向孟德尔随机化研究[J]. 预防医学, 2023, 35(5): 384-387,409.
[9] 马奕竹, 赵效国, 朱启英, 马依拉·买买提, 张环美, 苑晓琳, 李莉. 孕期膳食模式与妊娠糖尿病的关联研究[J]. 预防医学, 2023, 35(4): 286-290.
[10] 张红, 胡志明, 潘晓锋, 朱梦胜, 戴伟丽, 谢伊丽, 诸建方. 社区高血压患者Triangle分层分级管理效果评价[J]. 预防医学, 2023, 35(4): 350-354,358.
[11] 刘国志, 袁空军, 庄蔚, 周光清. 国内外城市社区2型糖尿病健康管理模式比较[J]. 预防医学, 2023, 35(3): 262-266.
[12] 顾逸藜, 孙晓燕, 谢臻蔚. 女性糖尿病与压力性尿失禁研究进展[J]. 预防医学, 2023, 35(2): 130-133.
[13] 谢睿, 胡菊莲, 喻喆. 妊娠糖尿病患者生活质量的影响因素研究[J]. 预防医学, 2023, 35(2): 162-165.
[14] 杨洋, 何田静, 祝淑珍, 张岚, 黄希宝. 成年人群睡眠与肥胖的关联研究[J]. 预防医学, 2023, 35(2): 116-120.
[15] 李娜娜, 张师静, 陈巧敏, 栗浩然, 王雅莉. 孕前体质指数与妊娠糖尿病的剂量-反应关系[J]. 预防医学, 2023, 35(10): 829-833.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed